MENU
NOV 12, 2020

Clinical Diagnostics & Research 2020

Eleven years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians, researchers, medical experts and professionals for the 11th time. LabRoots aims to elevate the level of collaboration and in turn, advance clinical diagnostics, research and medicine.

On November 12, 2020 thousands will join in a discussion of the continuous progress made with advances in laboratory testing and patient care and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices.

This year's event will include the following topics and tracks:
 
Advances in Diagnostics Technologies
  • Molecular
  • Point of Care
  • Proteomics
Leveraging Laboratory Data
  • Opioid Crisis
Considerations for Specific Patient Populations
Laboratory Stewardship and Patient Safety

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.



Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Clinical Diagnostics Virtual Event. Submission is free; submit your abstract here. 

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Use #LRclinical to follow the conversation!


Speakers

Show Resources
You May Also Like
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
FEB 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
FEB 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 10th annual Laboratory Animal Science (LAS) Virtual Conference which will take place on February 10th 2021. This is the premier on...
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 4th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 24, 2021. The Cannabis Sciences planning committee will be plannin...
MAY 19, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAY 19, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Welcome to the 5th Annual Laboratory Automation & Informatics Virtual Event ; a free virtual conference for professionals interested in the most recent technologies for today’s la...
Agenda
  • Extend your clinical reporting capabilities with QCI services
    NOV 12, 2020 4:30 PM PST
    Extend your clinical reporting capabilities with QCI services
    Ajay Athavale
    Senior Bioinformatics Engineer
    Sponsored By: QIAGEN
  • NOV 12, 2020 3:00 PM PST
    Translating insights into better outcomes: The new QIAseq Human Exome integrated solution
    Sponsored By: QIAGEN
    Brian Dugan, M.S.
    Associate Director, Global Product Manager - Genomics
    Rupert Yip, PhD
    Director, GPM Genetic Disease Informatics
  • Covid-19 Testing and the role of Antigen assays today and moving forward
    NOV 12, 2020 1:30 PM PST
    Covid-19 Testing and the role of Antigen assays today and moving forward
    Vincent Streva, PhD
    Associate Laboratory Director, Sherman Abramas Laboratory
    Sponsored By: DiaSorin
  • Measuring levels of neutralizing antibodies in SARS CoV-2 infected/recovered and vaccinated individuals using a high-throughput and cost-effective test
    NOV 12, 2020 12:00 PM PST
    Measuring levels of neutralizing antibodies in SARS CoV-2 infected/recovered and vaccinated individuals using a high-throughput and cost-effective test
    Sean Taylor, MBA, PhD
    Field Application Scientist Manager, North America, GenScript USA, Inc.
    Sponsored By: GenScript
  • Recovery of cfDNA using the QIAsymphony DSP Circulating DNA Kit
    NOV 12, 2020 10:30 AM PST
    Recovery of cfDNA using the QIAsymphony DSP Circulating DNA Kit
    Alexander Wolf, PhD
    Senior Scientist
    Sponsored By: QIAGEN
  • NOV 12, 2020 9:00 AM PST
    Back to Work, School, and Life: Utility of COVID-19 Testing to Help Communities Restore Normality
    Sponsored By: Thermo Fisher Scientific
    Dr. Jared R. Auclair
    Associate Dean of Professional Programs, College of Sci...
    Frank Ong, MD, CPI, CCRP
    Chief Medical and Scientific Officer, Everlywell
  • Keynote Presentation: Choosing Wisely lab utilization first steps: addressing the low hanging fruit
    NOV 12, 2020 7:30 AM PST
    Keynote Presentation: Choosing Wisely lab utilization first steps: addressing the low hanging fruit
    Jeannie Callum, BA, MD, FRCPC
    Professor of Laboratory Medicine and Pathobiology at the University of Toronto and Director of Laboratory Utilization at Sunnybrook Health Sciences Centre in Toronto
  • Standardization with Clinical Digital Pathology - The Ki-67 Case
    NOV 12, 2020 6:00 AM PST
    Standardization with Clinical Digital Pathology - The Ki-67 Case
    Dzenita Omanovic
    Clinical Development Engineer, Data Lead
    Sponsored By: Visiopharm®
  • Clinical utility of concussion injury biomarkers
    Clinical utility of concussion injury biomarkers
    Paul R. Johnson, PhD, MT(ASCP), DABCC, FAACC
    Associate Professor, Department of Clinical Laboratory Science, College of Health Professions, Upstate Medical University
  • Demonstrating the Value of Laboratory Medicine through Population Health
    Demonstrating the Value of Laboratory Medicine through Population Health
    Kathleen Swanson, M.S., R.Ph.
    Project Santa Fe Foundation Faculty
  • How Artificial Intelligence can facilitate the use of cardiac biomarkers?
    How Artificial Intelligence can facilitate the use of cardiac biomarkers?
    Dr. Pradeep Kumar Dabla
    MD, PGDHM, PGDBA, Professor, Department of Biochemistry, G.B.Pant Institute of Postgraduate Medical Education & Research (GIPMER), Associated to Maulana Azad Medical College
  • Laboratory Testing for Opioids
    Laboratory Testing for Opioids
    Jessica Boyd, PhD, FCACB
    Clinical Biochemist, Alberta Precision Laboratories, Clinical Associate Professor, Cumming School of Medicine, University of Calgary
  • Portable and Wearable Medical Devices: A Nanotechnology Approach
    Portable and Wearable Medical Devices: A Nanotechnology Approach
    Xiaowu (Shirley) Tang, PhD, PEng
    Associate Dean of Science, Research Professor of Chemistry & Waterloo Institute for Nanotechnology (WIN), University of Waterloo
  • Using laboratory data to improve health care delivery and patient outcomes
    Using laboratory data to improve health care delivery and patient outcomes
    Lawrence de Koning, PhD DABCC FAACC FCACB
    Associate Professor and Clinical Biochemist, Departments of Pathology and Laboratory Medicine and Cardiac Sciences, Cumming School of Medicine, University of Calgary and Alberta Precision Lab
  • Advances in Diagnostic Technologies
  • How Artificial Intelligence can facilitate the use of cardiac biomarkers?
    How Artificial Intelligence can facilitate the use of cardiac biomarkers?
    Dr. Pradeep Kumar Dabla
    MD, PGDHM, PGDBA, Professor, Department of Biochemistry, G.B.Pant Institute of Postgraduate Medical Education & Research (GIPMER), Associated to Maulana Azad Medical College
  • Advances in Diagnostics Technologies
  • Portable and Wearable Medical Devices: A Nanotechnology Approach
    Portable and Wearable Medical Devices: A Nanotechnology Approach
    Xiaowu (Shirley) Tang, PhD, PEng
    Associate Dean of Science, Research Professor of Chemistry & Waterloo Institute for Nanotechnology (WIN), University of Waterloo
  • Leveraging Laboratory Data
  • Demonstrating the Value of Laboratory Medicine through Population Health
    Demonstrating the Value of Laboratory Medicine through Population Health
    Kathleen Swanson, M.S., R.Ph.
    Project Santa Fe Foundation Faculty
  • Laboratory Testing for Opioids
    Laboratory Testing for Opioids
    Jessica Boyd, PhD, FCACB
    Clinical Biochemist, Alberta Precision Laboratories, Clinical Associate Professor, Cumming School of Medicine, University of Calgary
  • Using laboratory data to improve health care delivery and patient outcomes
    Using laboratory data to improve health care delivery and patient outcomes
    Lawrence de Koning, PhD DABCC FAACC FCACB
    Associate Professor and Clinical Biochemist, Departments of Pathology and Laboratory Medicine and Cardiac Sciences, Cumming School of Medicine, University of Calgary and Alberta Precision Lab
  • Consideration for Specific Patient Populations
  • Clinical utility of concussion injury biomarkers
    Clinical utility of concussion injury biomarkers
    Paul R. Johnson, PhD, MT(ASCP), DABCC, FAACC
    Associate Professor, Department of Clinical Laboratory Science, College of Health Professions, Upstate Medical University
  • Laboratory Stewardship and Patient Safety
  • Keynote Presentation: Choosing Wisely lab utilization first steps: addressing the low hanging fruit
    NOV 12, 2020 7:30 AM PST
    Keynote Presentation: Choosing Wisely lab utilization first steps: addressing the low hanging fruit
    Jeannie Callum, BA, MD, FRCPC
    Professor of Laboratory Medicine and Pathobiology at the University of Toronto and Director of Laboratory Utilization at Sunnybrook Health Sciences Centre in Toronto
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster


All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Dr. Jared R. Auclair
    Associate Dean of Professional Programs, College of Science, Northeastern University
    Biography

      Dr. Jared R. Auclair is currently the Associate Dean of Professional Programs in the College of Science at Northeastern University and Associate Teaching Professor in the Department of chemistry and chemical biology.  In addition, Dr. Auclair is the Director of the Biopharmaceutical Analysis Laboratory (BATL), the Asia-Pacific Economic Cooperation Center of Regulatory Excellence in Biotherapeutics and Advanced Therapies, and oversees the International Council for Harmonisation training. Lastly, Prof. Auclair serves as the Technical Supervisor for the Life Science Testing Center at Northeastern University, which is a state and CLIA-certified lab. Dr. Auclair collaborates with both academic researchers, industry, and government in the area of biopharmaceutical development and analysis. He has expertise in molecular biology, protein biochemistry, analytical chemistry, protein crystallography, and biological mass spectrometry; and is interested in use-inspired research for the biotechnology industry.

    • Ajay Athavale
      Senior Bioinformatics Engineer
      Biography

        As a senior Bioinformatician Ajay is responsible for custom services related to API integration from external systems to Qiagen Clinical Insight . He is also responsible for custom reporting services from the QCI platform including automated variant reporting policies and data export in various different formats. Ajay has a Masters in Bioinformatics from Northeastern University.

      • Jessica Boyd, PhD, FCACB
        Clinical Biochemist, Alberta Precision Laboratories, Clinical Associate Professor, Cumming School of Medicine, University of Calgary
        Biography

          Jessica Boyd is a Clinical Biochemist at Alberta Precision Laboratories (Calgary) and a Clinical Associate Professor in the Cumming School of Medicine at the University of Calgary. Dr. Boyd completed her Ph.D. in Analytical and Environmental Toxicology at the University of Alberta in 2012 and Clinical Biochemistry Fellowship training at Calgary Laboratory Services/University of Calgary in 2015. She is currently the co-director of the Analytical Toxicology Laboratory at APL-Calgary.  Her areas of interest include urine drugs of abuse testing, therapeutic drug monitoring and endocrine markers.

        • Jeannie Callum, BA, MD, FRCPC
          Professor of Laboratory Medicine and Pathobiology at the University of Toronto and Director of Laboratory Utilization at Sunnybrook Health Sciences Centre in Toronto
          Biography

            Jeannie L. Callum, MD, FRCPC, is a Transfusion Medicine Specialist and Hematologist at Sunnybrook Health Sciences Center in Toronto and Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She is the Director of Utilization for the Department of Laboratory Medicine and Molecular Diagnostics. She also serves as the sponsor lead for the Ontario Regional Blood Coordinating Network for Central Ontario. Her primary interests in transfusion medicine include error tracking and the management of the coagulopathy associated with traumatic injury and post cardiac surgery. She has been involved with numerous transfusion clinical trials including ABLE, PROPPR, FIIRST, TACS and FIBRES. She has written extensively about issues in transfusion medicine, publishing more than 100 peer-reviewed articles and authoring numerous book chapters. She also was the lead author on the Provincial (Ontario) transfusion handbook titled “Bloody Easy,” now preparing its fourth edition. In addition, she is on the editorial board for the “Transfusion Medicine Reviews” and “Transfusion” journals.

          • Lawrence de Koning, PhD DABCC FAACC FCACB
            Associate Professor and Clinical Biochemist, Departments of Pathology and Laboratory Medicine and Cardiac Sciences, Cumming School of Medicine, University of Calgary and Alberta Precision Lab
            Biography

              Dr. Lawrence de Koning is an Associate Professor at the University of Calgary and Clinical Biochemist with Alberta Precision Laboratories. He directs the pediatric clinical biochemistry testing laboratory at Alberta Children’s Hospital in Calgary, Alberta, Canada. Dr. de Koning’s clinical interests are in pediatric clinical biochemistry as it relates to the acute and chronic care of children with cardiac, metabolic and endocrine disorders. His research interests are in laboratory quality improvement and in the epidemiology of childhood and adult conditions with significant morbidity and mortality.

            • Brian Dugan, M.S.
              Associate Director, Global Product Manager - Genomics
              Biography
                Brian Dugan is Associate Director of Global Product Manager - Genomics for QIAGEN's miRNA portfolio. Brian received his MS from Georgetown University in molecular biology. Previously, he has worked in marketing and business development positions for NGS testing, as well as research at Eunice Shriver NICHD.
              • Dr. Pradeep Kumar Dabla
                MD, PGDHM, PGDBA, Professor, Department of Biochemistry, G.B.Pant Institute of Postgraduate Medical Education & Research (GIPMER), Associated to Maulana Azad Medical College
                Biography

                  Prof. (Dr) Pradeep Kumar Dabla is an experienced Chairperson with a demonstrated history of more than 17 yrs of Leadership & Administration while working in the hospital & health care industry. He is a laboratory physician skilled in Medical Devices, Molecular Biology, Biotechnology, Laboratory Medicine and Clinical Research. He is a strong research professional with a NABL Assessor ISO 15189:2012 focused in Medical Laboratory from National Accreditation Board for Testing and Calibration Laboratories (NABL), Quality Council, Govt. of India. He has assessed more than 100 medical labs for NABL accreditation till date. He has been closely associated with National Accreditation Board for Hospitals & Healthcare Providers (NABH) for preparing & maintaining quality services for Chacha Nehru Bal Chikitsalya (CNBC), first public sector superspeciality hospital to receive accreditation while working as Head, Deptt of Biochemistry & all labs. Currently, he is working as a Professor, Department of Biochemistry, G.B.Pant Institute of Postgraduate Medical Education & Research (GIPMER), Associated Maulana Azad Medical College (MAMC), Govt of NCT of Delhi. He is also serving as Consultant, International Core Committee of IFCC Task Force for Young Scientists (IFCC-TFYS), Core Member APFCB-Communication & Publication Committee and Member IFCC C-MHBLM (Emerging Technologies Division). He demonstrated leadership skills with team ability and served IFCC as Chair IFCC-TFYS (2015-2019) while working for networking, training, education and support programmes for young colleagues. He has completed MBBS from Maulana Azad Medical College, Delhi University and MD (Biochemistry) from Lady Hardinge Medical College, Delhi University, India. Further, to increase the proficiency in management, he pursued Post-graduation in the Business Administration & Hospital Management. He is also qualified with Advanced Training in Supply Chain Management, Govt. of NCT Delhi, India. Due to keen interest in research and laboratory medicine, he has been awarded Thrice for his research work in “Postmenopausal Women CAD Risk & Gene Polymorphism” and “Diabetic CAD Risk” and received other Five Awards & Travel Grants at International level and been invited many times as speaker, chair at National & International congresses. He has more than 40 research papers to his credit in reputed National & International journals apart from 4 book chapters, 2 books and more than 30 abstracts as a part of invited talks and papers presented. He is associated with reputed journals as editor, reviewer and advisory board member.

                • Paul R. Johnson, PhD, MT(ASCP), DABCC, FAACC
                  Associate Professor, Department of Clinical Laboratory Science, College of Health Professions, Upstate Medical University
                  Biography

                    Paul R. Johnson, Ph.D., MT(ASCP), D(ABCC), FAACC is an Associate Professor at Upstate Medical University in Syracuse, New York, where he teaches laboratory medicine courses in clinical biochemistry and statistics. He earned a Ph.D. degree in Biochemistry & Molecular Biology from the University of Louisville (KY) School of Medicine, and completed a medical technology fellowship in the Department of Pathology at Newton-Wellesley Hospital (MA). Dr. Johnson’s professional career in clinical pathology spans over 20 years. He has held positions in clinical chemistry, hematology, and immunology laboratories as a medical laboratory scientist; technical specialist at the College of American Pathologists (CAP); and was technical manager of a specialized diagnostic laboratory with focus on cardiovascular disease biomarker testing. At Upstate Medical University, his clinical research has focused on diagnostic utility of concussion injury biomarkers in human subjects, with secondary focus on applied statistics related to human biological variation. His work led to invited presentations at several clinical science conferences, along with recent publications on these topics in high-impact scientific journals including Clinical Chemistry and PLoS One.  He serves as peer-reviewer for several leading journals in the laboratory medicine field. Dr. Johnson holds professional board certifications from the American Society for Clinical Pathology and the American Board of Clinical Chemistry. In 2019, he was inducted as a Fellow into the Academy of the American Association for Clinical Chemistry.

                  • Dzenita Omanovic
                    Clinical Development Engineer, Data Lead
                    Biography

                      Dzenita is a Clinical Development Engineer at Visiopharm. She holds a M.Sc. in Biomedical Engineering with a focus on medical image analysis from the Technical University of Denmark. Over the last 5 years, she has been involved in the development of CE-IVD APPs for the Visiopharm software platform, including data sourcing and management, and she specializes in external collaborations and projects with a clinical/CE-IVD/FDA scope.

                    • Frank Ong, MD, CPI, CCRP
                      Chief Medical and Scientific Officer, Everlywell
                      Biography

                        Dr. Frank Ong is the Chief Medical and Scientific Officer at Everlywell, the digital health company poised to disrupt the 25 billion dollar lab testing industry by providing consumers with at-home lab testing kits that include insightful, easy-to-understand results. Dr. Ong leads the company's medical affairs including clinical laboratory operations, research, and clinical development including new test development. Prior to joining Everlywell, Dr. Ong held leadership positions at Guardant Health, Roche Diagnostics, and Illumina and served as a faculty member and researcher at Cedars-Sinai Medical Center, where he received research grants from the National Institutes of Health (NIH). He earned his medical degree from the Keck School of Medicine at the University of Southern California and holds graduate certificates in clinical and translational investigation, biodesign and medical device innovation and clinical trial administration from Stanford University, UCLA and University of California San Diego. He served his residency in the Department of Family Medicine at UCLA's Geffen School of Medicine. He resides in Austin, Texas

                      • Vincent Streva, PhD
                        Associate Laboratory Director, Sherman Abramas Laboratory
                        Biography

                          I have the expertise, leadership, training, and motivation necessary to successfully carry out the proposed research project.  I have a broad background in biology, with specific training and expertise in public health microbiology, particularly pertaining to serological responses to infectious diseases, including emerging infectious diseases.  My work includes clinical laboratory diagnostics research across a broad range of disciplines.  My particular focus currently is development and evaluation of high-quality clinical laboratory diagnostic tests, particularly for emerging or under-studied pathogens. Presently, work in our laboratory is focused on evaluation and development of serological assays for detection of antibodies against SARS-CoV-2.

                          My early publications addressed the role of mobile genetic elements in human cancers. My work has led to several novel findings in the field, including the clonal variation of human mobile elements in different cancers, the contribution of mobile elements to DNA double strand break repair, description of the extensive variation in full-length/active mobile elements between individuals, and the role of several DNA repair pathways, including nucleotide excision repair and transcription-coupled repair, in limiting damage from mobile elements in vivo. Additionally, my work developed several novel tools that are now widely used in the field of mobile elements including a high-throughput sequencing approach for mobile element identification, and a droplet digital PCR approach for detection of rare mobile element insertions in tumors.

                          Additionally, I have made substantial contributions to the field of infectious diseases through work on the human parasite Plasmodium falciparum where my work focused on identifying potential druggable targets in the malaria parasite. Together with collaborators, I have described a receptor activated kinase required for intraerythrocytic proliferation, identified a novel parasite cyclin H homolog required for cytokinesis of blood-stage parasites, identified a essential contractile ring protein that controls cell division in P. falciparum, and developed a novel anti-parasitic compound that retains activity against artemisinin-resistant parasite strains.

                          My recent clinical laboratory work includes evaluation of molecular and serological assays for the detection of Zika virus and Zika virus antibodies, and more recently evaluation and development of molecular and serological assays for the detection of SARS-CoV-2 and SARS-CoV-2 antibodies. Our early work has shown a significant link between the severity of patient symptoms and the subsequent immune response.

                        • Kathleen Swanson, M.S., R.Ph.
                          Project Santa Fe Foundation Faculty
                          Biography

                            During her career, Ms. Swanson has worked with a wide range of professionals in health care and business to develop and facilitate new programs.  Ms. Swanson has been recognized as a leader and mentor, served on several Board of Director positions and as an elected officer for state and national groups. Ms. Swanson practiced pharmacy in a variety of environments including inpatient, outpatient, clinical, managed care, and research.  In addition to her practice experience, she has overseen local and national programs for quality management, performance improvement and measurement systems.  More recently, Ms. Swanson worked as the Director of Clinical Solutions at TriCore Reference Laboratories where she led the development and implementation of state-wide population health initiatives for high prevalence conditions in New Mexico using laboratory data. Currently she is a member of the Project Santa Fe Foundation Faculty working with multi-site groups to demonstrate the value of laboratory insights to improve patient care and reduce total costs.

                          • Xiaowu (Shirley) Tang, PhD, PEng
                            Associate Dean of Science, Research Professor of Chemistry & Waterloo Institute for Nanotechnology (WIN), University of Waterloo
                            Biography

                              Professor Xiaowu (Shirley) Tang joined the Department of Chemistry & Waterloo Institute for Nanotechnology (WIN) at the University of Waterloo (UW) in 2006. Currently, she is the Associate Dean of Science, Research, and a member of the Board of Directors for WIN. During 2014-2017, she served as the Director of Nanotechnology Engineering (NE) program, Canada’s only undergraduate NE program. Prior to joining UW, she received her Ph.D. from Massachusetts Institute of Technology (MIT) and pursued postdoctoral work at Stanford University. She also had 3 years of industrial experience in Silicon Valley, California, and is a co-founder of LeNano Diagnostics, Inc, a company incorporated in 2016. The Tang group is internationally recognized for its pioneer work on hybrid nanobio- materials and devices, with contributions particularly to the material, surface, and physical chemistries dealing with carbon nanostructures. Of significance is the development of biomarker sensing platforms for early diagnosis and management of chronic diseases. A low-cost point-of-care testing platform based on carbon nanotube biosensors is currently under transition to commercialization. Another noteworthy aspect of Tang’s research is the creation of a class of hybrid scaffold materials for tissue engineering, which integrates functional nanostructures and biopolymers to offer extraordinary mechanical, electrical, and rheological properties. The new materials, combined with 3D-printing and microfabrication, could provide disruptive technologies for the fabrication of tissues/organs, which can find important applications in drug screening and regenerative medicine. Her work has led to publications on prestigious journals, such as Nature Nanotechnology, Nature Biotechnology, Journal of American Chemical Society, Advanced Materials, and Nano Letters, as well as patent applications, multiple industrial partnerships, media reports, and invited lectures. Prof. Tang received the Leader’s Opportunity Award from Canada Foundation for Innovation (CFI) in 2008 and the Stars in Global Health Award from Grand Challenges Canada in 2012, Award for Outstanding Mid-Career Achievements in Nanoscience and Nanotechnology, NanoOntario, in 2018.

                            • Sean Taylor, MBA, PhD
                              Field Application Scientist Manager, North America, GenScript USA, Inc.
                              Biography

                                Sean Taylor holds a Ph.D. and an MBA from McGill University and has spent the past ten years publishing articles, providing seminars, workshops and training videos to help the global scientific community achieve excellent data from western blotting, qPCR and digital PCR experiments. He has managed teams of Field Application Scientists (FAS) in Canada for over a decade who have helped thousands of scientists achieve their research goals. In his current role as North American FAS Manager for GenScript, he leads a dedicated team to continue the tradition of providing pertinent and timely information to help the scientific community overcome research hurdles to accelerate the production of high quality, publishable data, cost-effectively.

                              • Alexander Wolf, PhD
                                Senior Scientist
                                Biography

                                  Alexander Wolf is a Senior Scientist in Sample Preparation Technologies, Molecular Diagnostics Development at QIAGEN GmbH. Following completion of a PhD in Biochemistry and a 3-year post-doctoral fellowship at the Institute of Pharmacology Giessen, Germany, Dr. Wolf joined QIAGEN in 2012 and has focused on the liquid biopsy portfolio for the past 8 years. As technical lead of the Molecular Diagnostics Development team, he was mainly responsible for the development of the QS DSP Circulating DNA Kit which launched in 2017 and remains dedicated to customer support of this product today.

                                • Rupert Yip, PhD
                                  Director, GPM Genetic Disease Informatics
                                  Biography
                                    An industry veteran, Rupert has helped early NGS companies including Life Technologies and Illumina successfully commercialize their sequencing platforms while making bioinformatics more accessible to the late adopters. As the leader of QIAGEN Bioinformatics' Hereditary Disease Portfolio, he is responsible for QIAGEN's Knowledge offerings including HGMD, CentoMD, QIAGEN Knowledgebase, and Ingenuity Variant Analysis. Rupert has a Masters in Computer Science and a PhD in Physiology. He was a Howard Hughes Postdoctoral Fellow in Genetics at Harvard Medical School before joining the ranks of industry.
                                  Sponsored by

                                  For information on becoming a sponsor or exhibitor, please click here.


                                  C.E. Credits

                                  The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                  Committee

                                  To download the Program Committee brochure here.


                                  • Damien Gruson

                                    Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also ...

                                    See more See less
                                  • Brian McNally

                                    Brian McNally received his doctorate in Cell & Molecular Biology at University of Texas Southwestern Medical Center, where he focused on the transcriptional mechanisms governing polycystic kidney disease, renal cancer and development. His post-doctoral fellowship concentrated on ...

                                    See more See less
                                  • Paul M. Yip, PhD, FCACB, DABCC

                                    Dr. Paul Yip is Division Head of Clinical Biochemistry at Sunnybrook Health Sciences Center in Toronto, and is Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Prior to his current position, he was at University Health ...

                                    See more See less
                                  Help

                                  General LabRoots Questions

                                  email support@labroots.com  

                                  Virtual Events and Webinars

                                  Supported Configurations

                                  • Operating System Internet Explorer Firefox Chrome Safari
                                    Vista IE8+ FF10+ Chrome15+
                                    Windows 7 IE8+ FF10+ Chrome15+
                                    Windows 8 IE10 FF10+ Chrome15+
                                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                                  • Cookie settings: session cookies enabled
                                  • Browser configuration must have JavaScript enabled
                                  • Adobe Flash player 10.2 or later

                                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                  Internet Connection

                                  • A minimum of 100Kbps is recommended for audio-only events
                                  • A minimum of 300Kbps is recommended for speaker on-video events

                                  Computer Equipment

                                  • Screen Resolution: Minimum 1024x768
                                  • Video Card: 65,000 colors minimum
                                  • Sound card and speakers (or headphones) for hearing webcast in full format
                                  • Audio Card: 16-bit minimum
                                  • RAM: 512MB of free RAM

                                  Firewall Protocol

                                  • HTTP on port 80 or HTTPS on port 443
                                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                  Work-At-Home Attendees

                                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                  For A Seamless Experience

                                  When using a mobile device, FREE Mobile Apps are available:

                                  - For viewing Webinars:

                                  - For viewing Virtual Events

                                  Attendee Guide

                                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                  Virtual Event and Webinar Support:

                                  Continuing Education (CME/CE) Support

                                  Loading Comments...
                                  Show Resources
                                  Attendees
                                  • See more